Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-02
1999-11-16
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514277, 514311, 514307, 544402, 544162, 544392, 544396, 546124, 564182, 564185, 564306, 564 48, A61K 31495, C07D29504
Patent
active
059858818
ABSTRACT:
The invention relates to new compounds of general formula I ##STR1## and the pharmaceutically acceptable salts thereof, wherein A, B, Z, R.sup.1, R.sup.2, R.sup.3 and m are defined as in the specification, processes for preparing them and pharmaceutical compositions containing these compounds. The compounds are valuable neurokinin (tachykinin) antagonists.
REFERENCES:
patent: 3862946 (1975-01-01), Havera
patent: 5696123 (1997-12-01), Dollinger et al.
Colten, H.R. and Krause, J.E., "Pulmonary Inflammation--A Balancing Act," New Engl. J. Med.336:1094-1096 (Apr. 1997).
Lowe,III, Nonpeptide Tachy Kinin Antagonists, Med Res Rev. vol. 16, No. 6 527-545; 1996.
McLean., Antagonists of NKI Receptor Med Res Rev., vol. 16, No. 4, 297-317; 1996.
Henry., Substance P . . . . ,; 1993 Inflammatory Disease Therapy Ed: Bonney, 1993.
Moussaoui et al., European J. Pharmacol., 238, 1993 Nayes 421-424.
Briem Hans
Dollinger Horst
Jung Birgit
Schnorrenberg Gerd
Speck Georg
Boehringer Ingelheim KG
Bottino Anthony P.
Raymond Richard L.
Raymond Robert P.
Sripada Pavanaram K.
LandOfFree
Neurokinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurokinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurokinin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325029